Castle Biosciences, Inc. (CSTL) scores 40 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $16.52, representing a 35% premium to fair value. Quantitative score: 55/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.